Collaborative models to accelerate cell and gene therapy translation

Collaboration across academia, industry, and translational partners can address bottlenecks in CGT development. This spotlight presentation explores models that integrate expertise, share resources, and optimize workflows to accelerate program progression while maintaining scientific rigor.

Key takeaways

• Establish collaborative frameworks that connect discovery, preclinical, and clinical teams
• Leverage shared resources to strengthen translational fidelity and predictive validity
• Align decision criteria for dose selection, biomarker strategy, and safety margin evaluation
• Implement processes that support rapid iteration without compromising quality
• Enhance program readiness for first-in-human studies through coordinated approaches